Document Detail


Cardiovascular effects of oral pharmacotherapy in erectile dysfunction.
MedLine Citation:
PMID:  11329822     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Several drugs have been developed to treat patients with erectile dysfunction (ED). In general, patients prefer orally administered drugs. The use of these drugs (e.g. sildenafil and apomorphine) is reviewed. Because ED is a common problem in men with vascular disease it is important to assess the effect of these drugs on the cardiovascular system. The safe use of these drugs in patients with vascular disease needs to be clearly established in appropriately designed trials.
Authors:
Y Vardi; I Gruenwald
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current medical research and opinion     Volume:  16 Suppl 1     ISSN:  0300-7995     ISO Abbreviation:  Curr Med Res Opin     Publication Date:  2000  
Date Detail:
Created Date:  2001-05-01     Completed Date:  2001-09-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  England    
Other Details:
Languages:  eng     Pagination:  s42-7     Citation Subset:  IM    
Affiliation:
Neurourology Unit, Rambam Medical Center, Haifa, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arginine / adverse effects*
Cardiovascular Diseases / chemically induced*
Erectile Dysfunction / drug therapy*
Humans
Male
Neurotransmitter Agents / adverse effects*
Phosphodiesterase Inhibitors / adverse effects*
Piperazines / adverse effects*
Purines
Sulfones
Chemical
Reg. No./Substance:
0/Neurotransmitter Agents; 0/Phosphodiesterase Inhibitors; 0/Piperazines; 0/Purines; 0/Sulfones; 139755-83-2/sildenafil; 74-79-3/Arginine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The anatomy, physiology and molecular pathways of vascular erectile dysfunction.
Next Document:  Sildenafil: a urologist's view.